Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Vasospasm occurs frequently after aneurysmal subarachnoid hemorrhage and can lead to strokes.
The investigators will investigate if infusion of a novel drug, clevidipine, will decrease
vasospasm during the infusion and post infusion period using transcranial doppler monitoring
of patients with subarachnoid hemorrhage and moderate severity vasospasm